CODX Co-Diagnostics: Earnings growth forecast for next year
Shrinking demand for PCR tests has forced Co-Diagnostics, Inc. (CODX) to develop portable rapid diagnostics for small clinics. Patents for Co-Dx Design home systems serve as a hedge against dumping in an oversaturated sector. Shifts in target earnings per share estimates confirm this trend, where 72.90 captures the magnitude of this parameter. Revenues are based on the supply of DNA equipment and molecular tests for global medical centers.
Analytical breakdowns for Co-Diagnostics (CODX)
- price and consensus price forecast:
- company stock capitalization data:
- book capitalization indicators:
- company liabilities and liquidity data:
Total Debt to Capital Co-Diagnostics, Inc.|CODX - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital CoDx|CODX - Company Total Debt Obligations|Debts to Book Capitalization Co-Diagnostics, Inc.|CODX - Company Long-Term Debts|Company Short-Term Debts Co-Diagnostics|Quick Liquidity codiagnostics.com
- net income and valuation ratios data:
CODX - Company Profit|Expected Profit Co-Diagnostics, Inc.|CODX - Market Cap to Earnings|Future Price to Earnings Co-Diagnostics Inc|CODX - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Co-Diagnostics|CODX - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Co-Diagnostics|CODX - Net earnings per share for the last four quarters|Quarterly EPS earnings growth codiagnostics.com|CODX - Net earnings per share growth this year|Net earnings per share growth forecast for next year Co-Diagnostics, Inc.
- total revenue and sales volume data:
Initial company analysis:CoDx, CODX
When selecting stocks, asset reliability is determined by the projected return on equity. This indicator measures the expected percentage growth in earnings per share for the following year, currently reaching a value of 72.90. For Co-Diagnostics, Inc. (CODX), this calculation confirms the commercialization of new PCR systems and the stability of the R&D pipeline; therefore, the valuation of future earnings per share dynamics serves as a signal of the business's fundamental resilience.
Main competitors
A (agilent.com) - Earnings growth forecast for next year|DGX - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year ILMN|EXAS - Expected net earnings per share growth next year|Earnings growth forecast for next year RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Expected net earnings per share growth next year|Anbio Biotechnology - Earnings growth forecast for next year|Expected net earnings per share growth next year soterahealth.com|QDEL: Earnings growth forecast for next year|OPKO Health - Expected earnings per share trend next year|CDNA (CareDx, Inc) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year MRVI|Net earnings per share growth forecast for next year Fulgent Genetics (FLGT)|LAB (Standard BioTools Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year CTKB (Cytek Biosciences)|OraSure Technologies Inc (OSUR) - Expected net earnings per share growth next year|XGN - Net earnings per share growth forecast for next year|MDxHealth Inc. - Projected earnings per share increase next year|LUCD: Earnings growth forecast for next year|Prenetics Global Limited - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Insight Molecular Diagnostics, Inc.|trinitybiotech.com (TRIB) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year PRPH|Earnings growth forecast for next year Ainos Corp (AIMD)|Net earnings per share growth forecast for next year Heart Test Laboratories HSCS|BMRA: Projected earnings per share growth rate for next year|CDIO - Net earnings per share growth forecast for next year|Onconetix Corp (ONCO) - Expected earnings per share growth for next year|VRAX (Virax Biolabs Group Ltd) - Expected earnings per share growth for next year|Expected net earnings per share growth next year Bluejay Diagnostics Corp (BJDX)|AWH (Aspira Women's Health, Inc.) - Earnings growth forecast for next year|AXDX - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year centogene.com (CNTG)|Consensus forecast of earnings per share growth for next year Enzo Biochem|Consensus forecast of earnings per share growth for next year FRES|Net earnings per one share growth forecast for next year GTG Labs|23andMe Holding Co - Earnings growth forecast for next year|PMD - Earnings growth forecast for next year
